Anti-mifepristone court decisions rely on medical misinformation about abortion & questionable legal reasoning
The Food and Drug Administration approved mifepristone in the year 2000 for use in medication abortion up to seven weeks
Over half the antibiotic formulations India used in 2019 were unapproved
Despite being the largest antibiotic consumer in absolute volume globally, India lacks a formal system of antibiotic use surveillance
Number of antibiotics, investment not sufficient to minimise threat of wide-spread infection
Of the 12 antibiotics companies that have gone public in the past 10 years, only 5 are still active today
Study claims asthma drug can help fight COVID-19
Montelukast has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay …
Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA
Unclear which combination of updated vaccine will work best; body expected to decide by July
Ivermectin: why a potential COVID treatment isn’t recommended for use
There is currently insufficient evidence to support the use of ivermectin in treatment of COVID-19
Coronavirus update: US FDA cautions consumers against toxin in hand sanitisers
India registers highest single-day spike of 66,999 cases August 13; 942 deaths added in 24 hours
How safe is your hand sanitiser
The government hasn’t had much control over India’s hand sanitising manufacturers, who have mushroomed amid the COVID-19 pandemic
What is ‘dry ice’, at the centre of the Gurugram restaurant incident?
The solid form of carbon dioxide commonly used as a cooling agent in ice cream & frozen desserts must never be touched with ‘…
FDA gives EUA to first-ever breath test to detect a COVID-19 infection
A positive test, however, should be confirmed with a Polymerase Chain Reaction test
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively